All Comparisons/Lunit vs AZmed

VNDRIQ — Vendor Comparison

Lunit vs AZmed

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Lunit53
AZmed53

Lunit

Medical Imaging AI

Last verified: September 30, 2026

AZmed

Medical Imaging AI

Last verified: September 30, 2026

VNDRIQ Scores

53

Overall

Privacy Score36
Governance Score71
Healthcare Readiness49
AI Risk Score55

53

Overall

Privacy Score62
Governance Score33
Healthcare Readiness50
AI Risk Score65

Approval Tier

Approved With Restrictions
Restricted / Review Required

BAA Status

Available for clinical deployments in the United States following FDA clearance of core products.
Verify Directly

PHI Exposure Risk

High
Medium

AI Training Risk

Medium
Medium

HIPAA Risk Level

High
Medium

Review Frequency

Quarterly

—

Recommended Use

Adjunctive computer-assisted detection and diagnosis (CADe/x) for breast cancer in mammography and prioritization/triage of urgent findings in chest X-rays.

—

Restrictions

Intended for use as an adjunctive tool by interpreting physicians after an initial read; not a replacement for clinical judgment or complete clinician review.

—

Executive Summary

Lunit

Medical Imaging AI

Lunit is classified as Approved With Restrictions with a BAA status of Available for clinical deployments in the United States following FDA clearance of core products.. PHI exposure is rated High and AI training risk is Medium. Adjunctive computer-assisted detection and diagnosis (CADe/x) for breast cancer in mammography and prioritization/triage of urgent findings in chest X-rays.

36

Privacy

71

Governance

49

Healthcare

55

AI Risk

AZmed

Medical Imaging AI

AZmed is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Medium and AI training risk is Medium.

62

Privacy

33

Governance

50

Healthcare

65

AI Risk

Recommended For

Lunit

Adjunctive computer-assisted detection and diagnosis (CADe/x) for breast cancer in mammography and prioritization/triage of urgent findings in chest X-rays.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

AZmed

Currently under review — not recommended for active PHI deployment

Governance Considerations

Lunit

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Intended for use as an adjunctive tool by interpreting physicians after an initial read; not a replacement for clinical judgment or complete clinician review.

AZmed

BAA has not been confirmed. Execute BAA before processing PHI.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.